On September 23-25th, CSOFT will be attending the Medtech Conference in Boston along with 3,000 other attendees to network and share insight with medical technology industry leaders. Attendees will have the opportunity to witness more than 300 speakers discuss topics pertinent to today’s medical technology industry such as the increasing use of artificial intelligence, regulations […]
At 11:00 EDT on July 18, 2018 Joshua Hughman, Director of Business Development, Europe, who was previously the Director of Business development for our Global Communications department based in China at CSOFT International will be presenting a Webinar partnered with GALA (Globalization and Localization Association) about how he has found success in the Chinese translation […]
No matter what country you’re from, language you speak, or religion you believe in, enjoying delicious food together is an unchanging nature of mankind – allowing people to connect and appreciate the love of life by sharing stories over a good meal.
On January 30, 2019, the FDA approved the first generic version of Advair Diskus. This popular inhaler medication is one of the most commonly used prescriptions for treating Asthma and Chronic Obstruction Pulmonary Disease (COPD). This new license will provide patients with access to more affordable prescriptions. This advancement will also affect the drug market in other parts of the world.